Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Hydroxyethyl starch solutions should not be used in some critically ill patients
- Starting date:
- June 24, 2013
- Posting date:
- June 24, 2013
- Type of communication:
- Information Update
- Source of recall:
- Health Canada
- Important Safety Information
- General Public
- Identification number:
Health Canada and the manufacturers of blood volume expanders containing hydroxyethyl starch (HES) solutions recommend that these products no longer be used in critically ill patients with certain health conditions.
HES solutions are used to replace lost blood in patients who are critically ill and experience a sudden drop in blood pressure (for example, following surgery).
Specifically, HES solutions should not be used:
- in patients with sepsis (a serious complication that can develop from an infection),
- in patients with severe liver disease, and
- in certain types of patients with impaired kidney function.
Some recent studies have compared HES with other blood volume expanders in critically ill patients with sepsis. These studies suggest that patients treated with HES are at a higher risk of kidney failure or death.
Health Canada will work with the manufacturers to update the drug labels of these products and will communicate with healthcare professionals and consumers when the labels have been updated.